Sustainability

Home SustainabilityESG Data

ESG Data

Hisamitsu Pharmaceutical Group’s CO₂ emissions

Unit FY2020 FY2021 FY2022
Hisamitsu Pharmaceutical Group t ー 33,220 34,452
 Hisamitsu Pharmaceutical Co., Inc.
 [Non-consolidated]		 t 21,905 22,785 22,140
  Kyushu Head Office t 11,385 12,428 11,736
  Utsunomiya Factory t 6,100 6,240 6,242
  Tsukuba Laboratories t 2,579 2,183 2,132
  Tokyo Head Office /
  Branches and Sales Offices		 t 1,841 1,934 2,030
 Japan subsidiaries t ー 1,748 1,576
 Overseas subsidiaries t ー 8,687 10,736
Unit FY2020 FY2021 FY2022
(Non-consolidated)
CO₂ emissions per unit of sales   		 t/million yen 0.25 0.25 0.24

CO₂ emissions in the supply chain
(Hisamitsu Pharmaceutical Co., Inc.
[Non-consolidated]; Scope 1, 2, and 3)

Unit FY2020 FY2021 FY2022
Scope 1 t 6,986 6,923 7,862
Scope 2 t 14,919 15,862 14,278
Scope 3 t 89,353 93,816 98,488
 Category 1: Purchased goods and
 services		 t 51,179 48,284 49,823
 Category 2: Capital goods t 5,340 9,605 11,651
 Category 3: Fuel- and energy-related
 activities not included in Scope 1 or 2		 t 2,167 4,723 4,885
 Category 4: Transportation, delivery
 (upstream)		 t 2,161 2,039 2,234
 Category 5: Waste from business t 2,095 2,317 2,433
 Category 6: Business travel t 473 281 340
 Category 7: Employee commuting t 255 315 271
 Category 8: Leased assets (upstream) t ー ー ー
 Category 9: Transportation and delivery
 (downstream)		 t 32 30 33
 Category 10: Processing of sold products t ー ー ー
 Category 11: Use of sold products t ー ー ー
 Category 12: End-of-life treatment of
 sold products		 t 25,651 26,222 26,818
 Category 13: Leased assets
 (downstream)		 t ー ー ー
 Category 14: Franchises t ー ー ー
 Category 15: Investments t ー ー ー
Total t 111,258 116,601 120,628

*The values listed in the Database of emission intensity for Calculating Each Organization’s Greenhouse Gas Emissions throughout Its Supply Chain (Ver 3.2), Ministry of the Environment

Energy consumption
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; Crude oil equivalent)

Unit FY2020 FY2021 FY2022
Hisamitsu Pharmaceutical Co., Inc. kL 11,769 12,153 11,170
 Kyushu Head Office kL 6,630 7,049 6,687
 Utsunomiya Factory kL 3,098 3,186 3,168
 Tsukuba Laboratories kL 1,252 1,090 1,051
 Tokyo Head Office /
 Branches and Sales Offices		 kL 789 828 264
(Non-consolidated)
Energy consumption per unit of sales		 kL/million yen 0.14 0.13 0.12

Energy consumption by type
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Energy type Unit FY2020 FY2021 FY2022
Purchased electricity MWh 34,064 35,820 35,153
Steam supplied from an external heat source GJ 41,586 40,755 38,188
City gas ㎥ 1,160 809 363,094
LPG kg 4,235 4,546 5,835
Heavy oil A kL 1,708 1,732 985
Gasoline kL 620 656 657
Light oil kL 1 2 1
Kerosene kL 370 289 272

Energy consumption at overseas factories

Overseas subsidiaries Energy Unit FY2020 FY2021 FY2022
Noven Electricity MWh 11,152 10,709 10,302
Gas
（LNG）		 ㎥ 349,987 110,805 114,403
Light oil kL 1.2 0.0 0.0
Hisamitsu Vietnam Electricity MWh 3,323 2,386 3,773
Gas
（LPG）		 ㎥ 58,410 30,893 48,797
Light oil kL 4.4 2.1 2.7
Hisamitsu Indonesia Electricity MWh 2,308 2,357 3,274
Light oil kL 120.0 112.0 256.0
Hisamitsu Brazil Electricity MWh 2,645 2,544 2,489
Gas
（LPG）		 ㎥ 20,700 6,186 4,156
Light oil kL 54.9 49.8 36.0

Water consumption and drainage volume
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Water
consumption
by water
source		 Water consumption t 167,443 176,649 174,009
 Municipal potable water t 90,834 96,275 87,672
 Industrial water t 48,867 49,930 49,332
 Surface water from rivers, lakes,
 natural ponds, etc.		 t 0 0 0
 Groundwater from wells and
 boreholes		 t 27,742 30,444 37,005
 Used quarry water collected
 in the quarry		 t 0 0 0
 External wastewater t 0 0 0
 Harvested rainwater t 0 0 0
 Sea water, water extracted from
 the sea or the ocean		 t 0 0 0
Drainage
volume by
destination		 Drainage volume* t 86,243 92,801 86,520
 Sewage t 86,243 92,801 86,520
 Rivers* t ー ー ー
 Ocean t 0 0 0
 Surface water t 0 0 0
Amount recycled t 37,015 26,200 39,079
(Non-consolidated) Water consumption per unit of sales t/million yen 1.93 1.95 1.87

* Water that passes discharge standards is discharged into rivers. Wastewater volume is not known.

Water consumption and drainage volumes at overseas factories

Unit FY2020 FY2021 FY2022
Total of overseas subsidiaries Water consumption ㎥ 90,557 80,245 98,877
Drainage volume ㎥ ー ー ー
Noven Water consumption ㎥ 17,874 17,293 22,240
Drainage volume ㎥ ー ー ー
Hisamitsu Vietnam Water consumption ㎥ 47,053 33,255 50,519
Drainage volume ㎥ ー ー ー
Hisamitsu Indonesia Water consumption ㎥ 11,710 11,610 17,051
Drainage volume ㎥ ー 5,429 4,823
Hisamitsu Brazil Water consumption ㎥ 13,920 18,087 9,067
Drainage volume ㎥ ー ー ー

*Sampled water: Tap water for Noven, Hisamitsu Vietnam and Hisamitsu Indonesia; well water for Hisamitsu Brazil

Water pollutant emissions
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
BOD*1 emissions t 10.3 8.5 8.6
SS*2 emissions t 2.3 2.7 2.2

*1 BOD (biological oxygen demand): Value representing the amount of oxygen consumed when organics are decomposed by microorganisms in water
*2 SS (suspended solids): Volume of solid particles whose diameter is 2 mm or under that remain in suspension in water

Total waste emissions / Final waste disposal volume / Recycling rate
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Total waste generated t 3,223 3,607 3,722
Amount of resources recycled
(Amount of valuable resources)		 t 481 530 541
Recycling rate
(Valuable resource rate)		 % 14.9 14.7 14.5
Final waste disposal volume t 6.6 7.8 8.0
Final waste disposal rate % 0.20 0.22 0.21
(Non-consolidated)
Total waste generated per unit of sales		 t/million yen 0.04 0.04 0.04

Waste emissions at overseas factories

Overseas subsidiaries Unit FY2020 FY2021 FY2022
Total of overseas subsidiaries Total waste generated t 1,368 1,282 1,844
Noven Total waste generated t 319 287 399
 Amount of industrial waste t 77 240 347
 Amount recycled t 242 47 52
Hisamitsu Vietnam Total waste generated t 329 247 363
 Amount of industrial waste t 309 196 323
 Amount recycled t 20 51 40
Hisamitsu Indonesia Total waste generated t 59 135 444
 Amount of industrial waste t 59 97 399
 Amount recycled t ー 38 45
Hisamitsu Brazil Total waste generated t 661 613 638
 Amount of industrial waste t 628 572 593
 Amount recycled t 33 41 45

Handling Volume of PRTR Substances
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Toluene Handling volume t 3.4 3.3 3.7
Emission into the air t 0.2 0.2 0.2
Waste disposal Waste liquid treatment t 0.1 0.1 0.1
Combustion treatment t 3.1 3.0 3.4
Acetonitrile Handling volume t 3.8 4.3 3.3
Emission into the air t 0.0 0.0 0.0
Waste disposal Waste liquid treatment t 3.8 4.3 3.3
Combustion treatment t 0.0 0.0 0.0

*PRTR Act: A law that requires the release amounts of certain chemical substances into the environment to be monitored and reported to the government
*Waste disposal = “Handling volume” - “Emission into the air” = Combustion treatmen + Waste liquid treatment

Air pollutant emissions
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
SOx (sulfur oxide) emissions t 0.7 0.9 0.7
NOx (nitrogen oxide) emissions t 2.9 2.8 1.8

Acquisition status of ISO 14001 certification

Certification scope (organization name) Certification acquisition date Acquisition rate
Kyushu Head Office December 24, 1999 Acquisition rate at two domestic pharmaceutical manufacturing factories: 100%
Utsunomiya Factory

Acquisition status of ISO 45001 certification

Certification scope (organization name) Certification acquisition date Acquisition rate
Kyushu Head Office December 25, 2019 Acquisition rate at two domestic pharmaceutical manufacturing factories: 100%
Utsunomiya Factory

Compliance with environmental laws and regulations (Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Number of violations of environmental laws and regulations Case 0 0 0
 Number of violations related to water
 quality and quantity		 Case 0 0 0

Environmental accounting
Environmental Conservation Cost
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])Unit: 1,000 yen

Category FY2020 FY2021 FY2022
Facilities Expenses Total Facilities Expenses Total
Pollution prevention 36,342 1,330 26,992 28,322 0 33,164 33,164
Global environmental protection 65,899 102,929 68,127 171,056 307,300 98,274 405,574
Resource recycling 430,151 190,800 150,744 341,544 273,708 155,529 429,237
Upstream/Downstream 11,409 0 15,185 15,185 0 16,359 16,359
Management activities 63,573 0 67,912 67,912 0 68,214 68,214
Social activities 7,446 0 7,914 7,914 0 5,914 5,914
Environmental damage response 547 0 523 523 0 488 488
Other 0 0 0 0 0 0 0
Total 615,367 295,059 337,397 632,456 581,008 377,942 958,950

Environmental Conservation Effect
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Energy consumption
(crude oil equivalent)		 kL 11,769 12,153 11,170
CO₂ emissions t 21,905 22,785 22,140
SOx emissions t 0.7 0.9 0.7
NOx emissions t 2.9 2.8 1.8
Water consumption 1,000㎥ 167 177 174
Wastewater discharge 1,000㎥ 86 93 87
BOD emissions t 10.3 8.5 8.6
Waste emissions t 3,223 3,607 3,722

Percentage of hybrid vehicles in all corporate sales vehicles
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Percentage of hybrid vehicles % 88.1 90.7 93.5

Employee data
(Consolidated; As of the end of February each fiscal year)

Unit FY2020 FY2021 FY2022
Consolidated number of employees Person 2,770 2,784 2,769
 Number of domestic employees Person 1,645 1,644 1,579
 Number of overseas employees Person 1,125 1,140 1,190
 Number of male employees* Person ー ー 1,654
 Number of female employees* Person ー ー 1,115
 Ratio of female employees* % ー ー 40.3

* Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]/Domestic subsidiaries: As of the end of February; Overseas subsidiaries: As of the end of December

Employee data
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; As of the end of February each fiscal year)

Unit FY2020 FY2021 FY2022
Number of employees Person 1,583 1,587 1,521
 Number of male employees Person 1,130 1,119 1,070
 Number of female employees Person 453 468 451
 Ratio of female employees % 28.6 29.5 29.7
Ratio of female managers* % 6.3 7.1 7.9
Average age Age 37.8 38.0 38.9
Average length of service Year 14.1 14.4 15.3
Elderly employment rate % 3.00 3.18 3.29
Employment rate of
persons with disabilities		 % 1.94 1.99 1.95
Number of new employees Person 82 72 10
 Number of new male employees Person 50 45 4
 Number of new female employees Person 32 27 6
 Ratio of new female employees % 39.0 37.5 60.0
Mid-career hiring rate % 11 5 55
Voluntary turnover rate % 2.5 3.4 3.7

* As of the end of March each fiscal year

Gender wage difference
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; Ratio of women's wages to men's wages)

Unit FY2020 FY2021 FY2022
Regular employees % ー ー 76.1
Part-time/fixed-term employees % ー ー 92.6
All employees % ー ー 75.7

Data related to work-life management
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Number of days of paid leave taken Day 11.1 11.1 13.3
Rate of paid leave taken % 60.2 60.6 72.1
Number of employees taking maternity leave Person 38 30 31
Number of employees taking childcare leave Person 39 39 66
 Male Person 0 17 29
 Female Person 39 22 37
Rate of employees taking childcare leave % 36 40 72
 Rate of male employees taking childcare  leave % 0 24 50
 Rate of female employees taking
 childcare leave		 % 105 84 108
Rate of return to work after childcare leave % 92.0 98.0 98.4

Data related to occupational safety and health
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Number of workplace accidents Case 9 7 8
Number of workplace accidents requiring absence from work Case 3 2 3
Workplace accident frequency rate* % 0.82 0.55 0.85

*Number of casualties due to workplace accidents / Total work hours x 1,000,000

Data related to group support activities
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Support activities for NPOs and civic organizations by Hisamitsu-Hot-Heart Club

Unit FY2020 FY2021 FY2022
Number of groups supported Group 34 44 39
Donation amount 1,000 yen 3,400 4,400 3,900

Data related to disaster relief activities and fundraising activities
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated])

Unit FY2020 FY2021 FY2022
Donation*1 Yen 5,396,485 2,257,509 16,595,993
Provision of supplies*2 Pieces / Bottles (1)4,080pieces
(2)2,400bottles		 (3)5,040pieces ー
International charity drive*3 Yen 284,936 231,236 601,975

*1: Including donations from Hisamitsu-Hot-Heart Club and from employees
*2: Provision of supplies based on the Agreement of Support and Cooperation at the Time of a Disaster signed by the Japanese Red Cross Society in January 2020
(1)HisamitsuⓇIce Towel,(2)AirⓇSalonpasⓇ Icing Spray,(3)HisamitsuⓇ Refresh Body Sheet
*3: In FY2020 and FY2021, charity drives were held with donation boxes set up in order to help prevent the spread of COVID-19.

Directors / Corporate Auditors
(Hisamitsu Pharmaceutical Co., Inc. [Non-consolidated]; As of the end of February each fiscal year)

Unit FY2020 FY2021 FY2022
Directors Person 11 10 9
 Outside Directors Person 4 4 3
 Female Directors Person 0 0 0
 Ratio of Outside Directors % 36.4 40.0 33.3
Corporate Auditors Person 4 4 4
 Outside Corporate Auditors Person 2 2 2
 Ratio of Outside Corporate Auditors % 50.0 50.0 50.0
Number of meetings of the Board of Directors Time 8 9 7
Board of Directors meeting attendance rate (all Directors) % 97.8 100.0 97.0
Board of Directors meeting attendance rate (all Auditors) % 100.0 97.2 100.0
Number of meetings of the Board of Corporate Auditors Time 7 6 7
Number of meetings of the Nomination and Remuneration Committee Time 1 1 1

As of October 1, 2023, there are three Outside Directors (33.3%) and one female Director (11.1%) of the nine Directors.

Corruption prevention

Unit FY2020 FY2021 FY2022
Fines, penalties, and settlement costs related to bribery and anti-corruption violations 1,000 yen 0 0 0
Number of disciplinary dismissal cases due to bribery and anti-corruption violations Case 0 0 0
Political contribution amount 1,000 yen 0 0 0

PAGETOP